Passer au contenu principal

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

aligner
annoter
télécharger

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carboxamide > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carboxamide > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carboxamide > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > carboxamide > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organic amino compound > peptide > N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide

Terme préférentiel

N-[(2R)-4-amino-1-[[(2S,3R)-1-[[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12R,16R,19S,22R)-6,9,19-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-16-(2-methylpropyl)-2,5,8,11,15,18,21-heptaoxo-12-propan-2-yl-1,4,7,10,14,17,20-heptazacyclotetracos-22-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide  

Concept générique

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-J6FCKXJD-2

Télécharger ce concept :

RDF/XML TURTLE JSON-LD